Kemps Launches First-of-its-Kind Smooth Cottage Cheese for Kids
/PRNewswire/ -- Today, Kemps® is introducing Kemps® Smooth Cottage Cheese for kids, a revolutionary new cottage cheese with no curds and a smooth and creamy...
Source: prnewswire.com
Usage Survey News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Usage Survey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Usage Survey Today - Breaking & Trending Today
UnivDatos Market Insights Pvt. Ltd.: Middle East Media and Entertainment Market to Witness CAGR of 7.5% (2022-2028) Rising Regionalization Creating Demand for Broad Range of Themes and Genres For Filmmakers
NOIDA, India, Dec. 16, 2022 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights the Middle East Media and Entertainment Market was valued at USD 2 billion in 2020
Source: finanznachrichten.de
Middle East Media and Entertainment Market to Witness CAGR of 7.5% (2022-2028) Rising Regionalization Creating Demand for Broad Range of Themes and Genres For Filmmakers
/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights the Middle East Media and Entertainment Market was valued at USD 2 billion in...
Source: prnewswire.com
NPD: Convenience, Energy Savings, and Ambiance Among Top Reasons to Purchase Smart Home Devices in the U.S.
Port Washington, NY (PRWEB) December 23, 2021 -- In the home automation category security cameras represent the largest portion of revenue sales and are often
Source: prweb.com
Kemin Granted U.S. Patent for Treatment of Human Immune Function
Share this article Share this article DES MOINES, Iowa, May 4, 2021 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has been granted a United States patent (US 10,912,794) on the use of beta 1,3 glucan for modulating human immune function and treating intestinal inflammation. This new patent joins a previously issued patent (US 9,574,217) on the production of beta-glucan for immune modulation using algae from a proprietary strain of Euglena graci...
Source: prnewswire.com